1. Home
  2. ELVN vs RDW Comparison

ELVN vs RDW Comparison

Compare ELVN & RDW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • RDW
  • Stock Information
  • Founded
  • ELVN 2016
  • RDW 2020
  • Country
  • ELVN United States
  • RDW United States
  • Employees
  • ELVN N/A
  • RDW N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • RDW Military/Government/Technical
  • Sector
  • ELVN Health Care
  • RDW Industrials
  • Exchange
  • ELVN Nasdaq
  • RDW Nasdaq
  • Market Cap
  • ELVN 1.2B
  • RDW 1.2B
  • IPO Year
  • ELVN 2020
  • RDW N/A
  • Fundamental
  • Price
  • ELVN $20.90
  • RDW $10.19
  • Analyst Decision
  • ELVN Strong Buy
  • RDW Buy
  • Analyst Count
  • ELVN 5
  • RDW 8
  • Target Price
  • ELVN $41.20
  • RDW $16.56
  • AVG Volume (30 Days)
  • ELVN 563.5K
  • RDW 8.2M
  • Earning Date
  • ELVN 11-12-2025
  • RDW 11-05-2025
  • Dividend Yield
  • ELVN N/A
  • RDW N/A
  • EPS Growth
  • ELVN N/A
  • RDW N/A
  • EPS
  • ELVN N/A
  • RDW N/A
  • Revenue
  • ELVN N/A
  • RDW $261,353,000.00
  • Revenue This Year
  • ELVN N/A
  • RDW $34.83
  • Revenue Next Year
  • ELVN $20.05
  • RDW $41.86
  • P/E Ratio
  • ELVN N/A
  • RDW N/A
  • Revenue Growth
  • ELVN N/A
  • RDW N/A
  • 52 Week Low
  • ELVN $13.30
  • RDW $6.61
  • 52 Week High
  • ELVN $30.03
  • RDW $26.66
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 51.84
  • RDW 54.15
  • Support Level
  • ELVN $19.02
  • RDW $8.58
  • Resistance Level
  • ELVN $20.66
  • RDW $11.85
  • Average True Range (ATR)
  • ELVN 1.00
  • RDW 0.64
  • MACD
  • ELVN 0.09
  • RDW 0.32
  • Stochastic Oscillator
  • ELVN 69.85
  • RDW 56.39

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About RDW Redwire Corporation

Redwire Corp is engaged in mission-critical space solutions and reliable components for the next-generation space economy. It assists its customers in solving the complex challenges of future space missions and industries. The company's space infrastructure offerings include a broad array of modern products and services, which have been enabling space missions. The company's plan enables it to combine decades of flight heritage with a culture creating new technologies that are the building blocks of space infrastructure for government and commercial customers.

Share on Social Networks: